SS
IRON icon

Simplicity Solutions’s Disc Medicine IRON Stock Holding History

Simplicity Solutions’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$215K Buy
+3,716
New +$190K 0.01% 952

Other funds holding IRON

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Simplicity Solutions's IRON Position: Q4 2023 in Review

Simplicity Solutions opened a new position in Disc Medicine (IRON) in Q4 2023: 3,716 shares worth $215K. The stake represents 0.01% of the portfolio and ranks #952 among its holdings.

112 funds tracked by Wall St. Rank hold IRON as of Q4 2023.

  • Simplicity Solutions held 3,716 shares of Disc Medicine worth $215K as of Q4 2023.
  • Disc Medicine was a new Simplicity Solutions position in Q4 2023.
  • Disc Medicine made up 0.01% of Simplicity Solutions's portfolio in Q4 2023, its #952 holding.
  • 112 funds tracked by Wall St. Rank held Disc Medicine as of Q4 2023.

Based on Simplicity Solutions's 13F filing for Q4 2023, filed 29 Jan 2024.